Is there a way that you and we can work together to improve it?

It seems to me that the site lacks considerable information and has proven to be difficult to navigate.

And at the moment, there is the balance in Hatch-Waxman and then there is the balance in the Orphan Drug Act and we are trying to move forward in rare diseases.

Clearly, we need to do more.

Is that the consensus of the panel?

MODDERN Cures is completely bipartisan in its sponsorship.

It seems to me we need some progress in these terrible rare diseases.

I have no doubt that there are frivolous demand letters that are sent, and we should do all that we can to crack down on this abuse, from my perspective, we also must be careful lest we unintentionally hurt legitimate investors.

It is my view that Congress are the last people on earth who should suggest that you should be locked in a room to solve the problems of the United States.

I am deeply concerned about the slashing of R&D budgets that may look good on a financial spreadsheet, but I think would be tragic for patients moving forward.

I believe that some of my colleagues on the other side of the aisle would prefer a Title II reclassification, and if the Commission were to decide to proceed in that direction, I am concerned that it might trigger a lot of ill-fitting…